Aenova is a leading global CDMO providing end-to-end pharmaceutical services from development to commercialization. The company supports all major dosage forms (solid, semisolid, sterile and nonsterile liquids), drugs up to OEB 5, and food supplements for human and veterinary use. With 14 manufacturing sites and 7 Development Competence Centers across Europe and the US, Aenova offers formulation, manufacturing, packaging, regulatory support, and logistics.

At AseBio, the Spanish Bioindustry Association, we have been uniting and representing the interests of companies, associations, foundations, universities and technological & research centers involved in biotech in Spain. We work closely with regional, national, European administrations and social organizations committed to science and the use of biotechnology.

BIOSPAIN 2027: 28-30 September 2027, Barcelona.

Cambrex is a leading global contract development and manufacturing organization (CDMO) that provides drug substance development and manufacturing across the entire drug lifecycle, as well as comprehensive analytical services.

Centaur Clinical CRO is a French CRO specialized in medical device clinical research, covering Phases I-IV across all therapeutic areas. Our agile, compact structure means faster decisions, quicker turnaround, and lower costs than larger CROs — without compromising on regulatory rigor under EU MDR. Operating across Europe, we build close, trust-based relationships with sites and sponsors. Agile by design, European by focus: your responsive CRO partner for medical devices.

Clubster NHL – Nutrition, Health, Longevity – is a French competitiveness cluster federating 300 members in the Nutrition, biotechnology and health sectors. We foster collaboration between academia, private companies (start-up, SMEs and large companies), clinicians and final users. Our aim is to help our members to design, develop and finance their innovative products and processes. The activity encompasses the ONE HEALTH concept, close relation between human, animal and plant health.

Collaborative Drug Discovery (CDD) provides an intuitive software suite trusted by global researchers in academia and industry. Its flagship platform, CDD Vault, enables teams to securely organize, analyze, and share chemical and biological data via a streamlined interface. Featuring AI-ready data tagging, it supports entity registration, inventory management, and SAR analysis. Since 2004, CDD has empowered thousands of scientists to advance efficient, data-driven drug discovery.

CordenPharma is a CDMO partner supporting biotech & pharma innovators of complex modalities in the advancement of their drug development lifecycle with bespoke outsourcing services from early clinical-phase development to commercialization. With scientific expertise and partnership at its core, CordenPharma provides high-value, end-to-end services with a strategic focus on Peptides, Oligonucleotides, customized Lipid Excipients, Lipid Nanoparticles, sterile Injectables and Small Molecules.

ERBC is a leading preclinical CRO bridging research and clinical success. We deliver predictive models, integrated services, and expert consultancy to de-risk innovation and accelerate R&D. Operating from state-of-the-art European facilities, our teams provide customer-centric, ethical solutions, advancing alternatives to animal testing.

Eurasanté is a development agency dedicated to tech transfer and business development in life sciences sector in Northern France region. Our experienced project managers help researchers, startups and companies with their development projects. To do so, Eurasante provides many services such as real estate, fundraising, recruitment and business development. It also promotes the Eurasante Bio-business Park, which already hosts 12 hospitals, 4 universities, 8 specialised schools and more than 200 companies. It benefits from an exceptional location at the heart of Europe.

Eurofins Optimed is a full-service Contract Research Organisation (CRO) specialising in early-phase clinical research. Based in France, we support pharmaceutical, biotechnology and medical device companies with Phase I studies, clinical pharmacology, patient recruitment and project management. As part of the Eurofins network, we provide high-quality, tailored solutions to accelerate drug development.

GMED and its subsidiaries, GMED North America and GMED Asia, support manufacturers of medical devices and IVDs throughout their certification journey, regardless of product risk level or technological innovation. As a Notified Body and Certification Body, GMED is internationally recognized for its expertise in conformity assessment (CE marking, QMS certification, MDSAP).Choose GMED as your trusted partner to navigate complex regulations and bring your device to market with confidence.

Intravacc is a specialized vaccine CDMO accelerating human and veterinary vaccines from concept to clinical proof of concept. With 100+ years of expertise, we combine innovative viral, bacterial, conjugate and protein platforms with process and analytical development and cGMP manufacturing. From promising science to scalable, clinic-ready vaccines, our experts solve complex development challenges and help partners bring the next generation of vaccines closer to patients and animals.

Discover our large-scale storage freezers, each holding up to 4,800 liters, replacing 42 single upright freezers, while freeing up 75% of valuable floorspace. With built-in redundancy, our solution ensures fail-safe storage and extremely tight temperature control with only ±1°C deviation across all products, enabled by advanced airflow cooling. You get maximum product protection, stable ultra-low temperatures and up to 66% lower electricity consumption.

We’re a niche player, mid-size CDMO dedicated to providing exceptional quality and efficient timelines.
With specific capabilities and an integrated network across Europe, we offer the extensive expertise in development needed to ensure a seamless journey from concept to commercialization, and a particular specialization and deep knowledge in sterile multidose, sterile and non-sterile lyophilized products and API, sachets and stick packs.

With 270 employees, Mora is a high-tech industrial group specialized in the production of thermoplastic injected parts for the medical, automotive and defence sectors.
We support our customers in the development and industrialization of complex projects. Our customers also benefit from our expertise in peripheral processes complementing the injection process, such as assembling subassemblies, decoration, packaging and the control of outsourced operations (sterilisation for example).

MyData-TRUST is a global leader in Data Privacy and Data Protection services, dedicated exclusively to the Life Sciences sector, with offices in Europe and N. America. We helped over 800 organizations safeguard health data, reduce risk and enhance compliance while enabling innovation.
Our multidisciplinary team (combining legal, IT security, and clinical research expertise) delivers practical, business-oriented solutions covering the full spectrum of privacy needs including DPO and DPR services.

The group offers an effective and environmentally responsible solution against all infections and contamination through its Sanivap & Nocotech product range. SANIVAP, a French manufacturer, is the market leader and the benchmark in the field of steam-based bio-cleaning.

OXY’PHARM designs, manufactures and markets its concept for automated bio-disinfection of surfaces using dry diffusion. Treatments comply with the EN 17272 standard.

Syngulon is a synthetic biology startup that develops original genetic technologies using bacteriocins with core applications:
1. Antibiotic-free genetic selection – sustainable alternatives to antibiotic resistance markers for recombinant protein production. March 2026: we announced a non-exclusive licensing agreement with Elanco Animal Health.
2. Next-generation antimicrobials – novel bacteriocin-based molecules offering targeted strategies against resistant pathogens (on-going project in AH).

Vernalis collaborates with pharma and biotech partners (including Servier, Pierre Fabre, Novartis, GSK and Lundbeck) to solve early drug discovery challenges. Via flexible collaboration models our services include HitID, FBDD, SBDD, advanced biophysics, structural biology, assay development, cell-based assays, molecular modelling and medicinal chemistry. As an independent subsidiary of HitGen, we also offer world leading DEL technology and expanded services within Vernalis led programmes.

WEGA : Your Trusted Partner for Digitalization, Data Strategy and AI in Life Sciences and Specialty Chemistry
We support life science and chemistry organizations in modernizing and operating their IT systems and data landscapes across the entire value chain – from research and clinical development to manufacturing. For this purpose, our 360° digitalization services span strategic consulting, system implementation, computer system validation and lifecycle management of Life Sciences IT platforms.